INDICATIONS     CONTRA-INDICATIONS     DOSAGE     SIDE-EFFECTS     PREGNANCY     OVERDOSE     IDENTIFICATION     PATIENT INFORMATION

Logo NEUROBION® TABLETS

SCHEDULING STATUS:
S0

PROPRIETARY NAME
(and dosage form):

NEUROBION® TABLETS

COMPOSITION:
Each tablet contains
  Vitamin B1         100 mg
  Vitamin B6         200 mg
  Vitamin B12         200 micrograms

PHARMACOLOGICAL CLASSIFICATION:
A.22.1.4 - Vitamins: Others

INDICATIONS:
NEUROBION tablets are indicated where a deficiency of the relevant vitamins exists.

CONTRA-INDICATIONS:
NEUROBION should not be used in patients on Levodopa therapy.
Hypersensitivity to any of the above ingredients.

DOSAGE AND DIRECTIONS FOR USE:
NEUROBION tablets may be administered in a dosage of 1 daily.

SIDE-EFFECTS AND SPECIAL PRECAUTIONS:
Cyanocobalamin should not be given before a diagnosis has been fully established because of the possibility of masking symptoms of subacute degeneration of the spinal cord.
Cyanocobalamin is not a suitable form of Vitamin B12 for the treatment of optic neuropathies associated with raised plasma concentrations of cyanocobalamin.

KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT:
Treatment is symptomatic and supportive.

IDENTIFICATION:
White, shiny, round coated tablets, steeply convexed on both sides.

PRESENTATION:
Clear glass bottle containing 10 tablets.
Amber glass bottle containing 100 tablets.

STORAGE INSTRUCTIONS:
Store below 25°C
KEEP OUT OF REACH OF CHILDREN.

REFERENCE NUMBER:
H2487 (Act 101/1965).

NAME AND BUSINESS ADDRESS OF THE APPLICANT:
Merck (Pty) Ltd.
Reg. No. 1970/04059/07
1 Friesland Drive
Longmeadow Business Estate
Modderfontein, 1645

DATE OF PUBLICATION OF THIS PACKAGE INSERT:
11 March 1988

® = Registered Trade Mark

                F70548 P05/03
                Highland Print

Updated on this site: November 2004
Source: Community Pharmacy

SAEPI HOME PAGE      TRADE NAME INDEX      GENERIC NAME INDEX      FEEDBACK
Information presented by Malahyde Information Systems © Copyright 1996-2004